ANI Pharmaceuticals President and CEO Lalwani Nikhil sold 5,400 shares at $71 each on September 15, 2026. After the transaction, he held 339,089 shares, while the sale equaled about 1.6% of his prior holding, giving investors the disclosed size of the transaction relative to his stake.

Key Highlights

  • Lalwani Nikhil held 339,089 shares after the transaction.
  • The sale represented about 1.6% of his prior shares holding.
  • The filing reports SEC transaction code S for the trade.

ANI PHARMACEUTICALS INC (NASDAQ: ANIP) saw its PRESIDENT & CEO, Lalwani Nikhil, sell 5,400 shares at $71 per share. The transaction took place on September 15, 2026, with the reported price applying to each share transferred.

Post-Transaction Holding: 339,089 Shares

The transaction is reported under SEC transaction code S. Lalwani Nikhil held 339,089 shares after the transaction. The reported sale represented about 1.6% of his prior shares holding. ANI Pharmaceuticals Inc identified Lalwani Nikhil as its PRESIDENT & CEO in the transaction details. Transaction code S denotes an open-market or private sale.